News

PLAYSTUDIOS Reports Strong Q3 Performance with Key Gains

PLAYSTUDIOS Reports Strong Q3 Performance with Key Gains

PLAYSTUDIOS, Inc. Delivers Strong Third Quarter Results

PLAYSTUDIOS, Inc. (NASDAQ: MYPS), recognized for its innovative approach as a developer of free-to-play mobile and social games, recently released its impressive financial results for the third quarter of the year. This marks a significant achievement for the Company as it navigates through industry's various challenges, showcasing resilience and strategic growth.

Financial Highlights of the Third Quarter

Revenue and Earnings Overview

In the latest quarter, PLAYSTUDIOS reported revenues of $71.2 million, marking a decrease from $75.9 million in the same period last year. However, the net loss was narrowed down to $3.1 million compared to $3.8 million from the previous year, illustrating improved efficiency and cost management.

Increased AEBITDA

The Company achieved a Consolidated AEBITDA (Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization) of $14.6 million for the quarter, compared to $13.5 million in the previous year. This notable performance contributed to an AEBITDA margin of 20.5%, reflecting a positive trend in profitability.

Strategic Initiatives Taking Shape

Reinvention Program

Andrew Pascal, Chairman and CEO of PLAYSTUDIOS, highlighted the launch of a significant reinvention program aimed at optimizing operations. This initiative is expected to result in meaningful cost reductions and improvements in the Company’s profitability, positioning it well for future growth.

Investments in Game Development

PLAYSTUDIOS also continues to enhance the monetization strategies within its existing portfolio. The expansion into the Tetris brand and integration of playAWARDS into its platform are key elements designed to bolster long-term engagement of players.

Player Engagement and Monetization Metrics

Key Performance Indicators

During the third quarter, PLAYSTUDIOS recorded an average of 3.0 million daily active users (DAU) and 12.7 million monthly active users (MAU). This reflects the successful adaptation to industry conditions and growing interest in the Company’s gaming offerings.

playAWARDS Platform Success

Players eagerly engaged with the playAWARDS loyalty platform, achieving significant milestones in rewards redeemed. Notably, 451,300 rewards were purchased at a retail value of $25 million, indicating a robust engagement with both existing and new players.

Future Outlook

PLAYSTUDIOS remains optimistic about its financial future, maintaining its 2024 guidance with net revenue anticipated in the range of $285 million to $295 million and AEBITDA between $55 million to $60 million. This indicates a bullish outlook for growth and financial health.

Conference Call to Discuss Results

The Company will host a conference call to further discuss these results, allowing investors and stakeholders an opportunity to engage directly with EXECUTIVE leadership.

About PLAYSTUDIOS, Inc.

PLAYSTUDIOS is renowned for developing engaging mobile games, blending interactive entertainment with real-world rewards through its playAWARDS loyalty program. Its diverse portfolio includes iconic titles such as the Tetris mobile app, Pop! Slots, and myVEGAS Blackjack, providing players exciting opportunities and experiences.

Frequently Asked Questions

What were the total revenues reported by PLAYSTUDIOS for Q3?

PLAYSTUDIOS reported total revenues of $71.2 million for the third quarter.

How does the third quarter revenue compare to last year?

The revenue for Q3 2024 decreased from $75.9 million reported in Q3 2023, though net loss improved.

What strategic initiatives has PLAYSTUDIOS implemented?

PLAYSTUDIOS has initiated a reinvention program aimed at optimizing costs and improving efficiency for sustainable growth.

What were the engagement metrics for the playAWARDS platform?

During Q3, players redeemed 451,300 rewards worth a total retail value of $25 million via the playAWARDS platform.

What is the future revenue guidance for PLAYSTUDIOS?

PLAYSTUDIOS maintains guidance for 2024 net revenue between $285 million and $295 million with AEBITDA of $55 million to $60 million.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading

Top 5 Most Recently Viewed Articles

GeeLark's Mobile-Cloud Push Redefines Social Media Ops

Updated Category News Views 8

Riding the Mobile Wave: A New Era in Digital Marketing Folks, GeeLark's latest move is like a sledgehammer to an old wall. Smashed it with their recent rollout of a unified Browser and Cloud Phone platform. This isn't just upgrading the toolbox—it's overhauling the whole workshop. As someone who's seen enough tech promises fizzle, this one might actually stick....

Continue Reading
Seven & i Holdings Expands Convenience Store Footprint Across North America

Updated Category News Views 377

Seven & i Holdings Plans Major Expansion in North America Japan's Seven & i Holdings has unveiled its ambitious plan to establish 500 new convenience stores in the United States and Canada by 2027. This strategic move comes as the company seeks to solidify its presence in the North American market and compete against local and international convenience store chains....

Continue Reading
How Russia Has Embraced Bitcoin Amidst Economic Challenges

Updated Category News Views 212

Bitcoin's Enduring Presence in Russia Not long ago, Russian President Vladimir Putin took a bold stance by declaring that Bitcoin could not be banned, regardless of any attempts by governments around the globe. This declaration underscored a potential shift in the country's approach to cryptocurrency amidst the backdrop of escalating international sanctions. Putin's...

Continue Reading
Jumptuit Receives USPTO Allowance for Innovative AI Patent

Updated Category News Views 363

Jumptuit's Progress in Artificial Intelligence Technology Jumptuit, a prominent company in the field of AI research and development, has recently marked a significant milestone in its innovative journey. The U.S. Patent and Trademark Office (USPTO) has granted Jumptuit a Notice of Allowance, enhancing its protection for cutting-edge AI Search Technology. This development...

Continue Reading
Harbour BioMed Unveils Promising Results for HBM1020

Updated Category News Views 110

Harbour BioMed Shares Exciting Results for HBM1020 Harbour BioMed, a global biopharmaceutical company dedicated to creating groundbreaking antibody therapeutics, has reached significant milestones in its clinical research. The company recently shared incredible clinical data on HBM1020, a first-of-its-kind fully human anti-B7H7/HHLA2 monoclonal antibody. This information...

Continue Reading